Environmental support services group has delivered strong interim results and remains in takeover talks.
In the face of economic uncertainty, environmental support services group Fountains, famed for its vegetation management expertise, delivered strong results for the half to March.
Under CEO Richard Haddon, Fountains has diversified its service range, adding activities such as street cleaning, graffiti removal and waste collection to its grass cutting and tree maintenance core, thereby dramatically expanding its addressable markets. At the same time, the company has focused on larger deals with greater longevity and raised levels of efficiency and innovation.
The benefits of this strategy were revealed at the interim, with operating profits (before bid and board change costs) growing by a third to £800,000, the best half-year operating profit in Fountains’ history.
Pre-tax profits came in at a creditable £388,000 (2008: £650,000), while the interim dividend was increased to 1.25p (2008: 1.1p), underpinned by a significantly improved cash performance.
Turnover growth from £20.7m to £21.2m was modest, however the rail sector, where Fountains previously encountered contract delays, came back strongly and the utility and local authority markets proved profitable hunting grounds.
Encouragingly in February, Fountains clinched its largest-ever contract, a three-year, diverse deal with British Waterways, worth in excess of £5m per annum. And there could be more to come, with Haddon stating ‘we are winning more diverse contracts and our pipeline has much larger contracts with greater longevity within it’.
We think shares in Fountains, which have fallen from a 52-week peak of 135p to present levels, should reclaim further ground given recent strong trading, contract momentum and the improving visibility levels within the business. Furthermore, the company remains in offer talks, which could add some significant extra spice in the months ahead. Buy.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Market cap: £9.847m
PE Forecast: n/a
Share price: 65.5p
Growth Company Investor is the leading magazine for investors in AIM and boasts award-winning research and analysis coverage.
Subscribe now and receive a 50% discount
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Fast-growing Alliance Pharma is to buy most of Cambridge Laboratories' trade and assets for £14.3m and £16.4m.
Investors seeking to back a business with exceptionally high earnings visibility and a burgeoning order book should look no further than Norwich-based infrastructure services specialist May Gurney.
Staff rostering software specialist Allocate, buoyed by 27% organic growth in the six months to November, aims to speed expansion with several acquisitions in coming years.